Literature DB >> 19643932

Considerations in the statistical analysis of hemodialysis patient survival.

Christos Argyropoulos1, Chung-Chou H Chang, Laura Plantinga, Nancy Fink, Neil Powe, Mark Unruh.   

Abstract

The association of hemodialysis dosage with patient survival is controversial. Here, we tested the hypothesis that methods for survival analysis may influence conclusions regarding dialysis dosage and mortality. We analyzed all-cause mortality by proportional hazards and accelerated failure time regression models in a cohort of incident hemodialysis patients who were followed for 9 yr. Both models identified age, race, heart failure, physical functioning, and comorbidity scores as important predictors of patient survival. Using proportional hazards, there was no statistically significant association between mortality and Kt/V (hazard ratio 0.72; 95% confidence interval 0.45 to 1.14). In contrast, using accelerated failure time models, each 0.1-U increment of Kt/V improved adjusted median patient survival by 3.50% (95% confidence interval 0.20 to 7.08%). Proportional hazard models also yielded less accurate estimates for median survival. These findings are consistent with an additive damage model for the survival of patients who are on hemodialysis. In this conceptual model, the assumptions of the proportional hazard model are violated, leading to underestimation of the importance of dialysis dosage. These results suggest that future studies of dialysis adequacy should consider this additive damage model when selecting methods for survival analysis. Accelerated failure time models may be useful adjuncts to the Cox model when studying outcomes of dialysis patients.

Entities:  

Mesh:

Year:  2009        PMID: 19643932      PMCID: PMC2736780          DOI: 10.1681/ASN.2008050551

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

1.  Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).

Authors:  D L Sackett
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

2.  Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial.

Authors:  D C Miskulin; N V Athienites; G Yan; A A Martin; D B Ornt; J W Kusek; K B Meyer; A S Levey
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

Review 3.  Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease.

Authors:  N V Athienites; D C Miskulin; G Fernandez; S Bunnapradist; G Simon; M Landa; C H Schmid; S Greenfield; A S Levey; K B Meyer
Journal:  Semin Dial       Date:  2000 Sep-Oct       Impact factor: 3.455

4.  Choice of parametric accelerated life and proportional hazards models for survival data: asymptotic results.

Authors:  J L Hutton; P F Monaghan
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

5.  Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.

Authors:  A Rashid Qureshi; Anders Alvestrand; José C Divino-Filho; Alberto Gutierrez; Olof Heimbürger; Bengt Lindholm; Jonas Bergström
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

6.  Oxidants and antioxidants in long-term haemodialysis patients.

Authors:  J Drai; E Bannier; C Chazot; J M Hurot; G Goedert; G Jean; B Charra; G Laurent; P Baltassat; A Revol
Journal:  Farmaco       Date:  2001 May-Jul

7.  Physical activity levels in patients on hemodialysis and healthy sedentary controls.

Authors:  K L Johansen; G M Chertow; A V Ng; K Mulligan; S Carey; P Y Schoenfeld; J A Kent-Braun
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

8.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Authors:  Ramón Paniagua; Dante Amato; Edward Vonesh; Ricardo Correa-Rotter; Alfonso Ramos; John Moran; Salim Mujais
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

9.  Association of nutritional markers with physical and mental health status in prevalent hemodialysis patients from the HEMO study.

Authors:  Kristina L Allen; Dana Miskulin; Guofen Yan; Johanna T Dwyer; Anne Frydrych; June Leung; Diane Poole
Journal:  J Ren Nutr       Date:  2002-07       Impact factor: 3.655

10.  Validation of a two-pool model for the kinetics of beta2-microglobulin.

Authors:  S Stiller; X Q Xu; N Gruner; J Vienken; H Mann
Journal:  Int J Artif Organs       Date:  2002-05       Impact factor: 1.595

View more
  4 in total

1.  Modeling survival of arteriovenous accesses for hemodialysis: semiparametric versus parametric methods.

Authors:  Pietro Ravani; Patrick Parfrey; Jennifer MacRae; Matthew James; Robert Quinn; Fabio Malberti; Giuliano Brunori; Salvatore Mandolfo; Marcello Tonelli; Brenda Hemmelgarn; Braden Manns; Brendan Barrett
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-22       Impact factor: 8.237

2.  Health-related quality of life and long-term mortality in young and middle-aged hemodialysis patients.

Authors:  Vladimir A Dobronravov; Irina A Vasilieva
Journal:  Int Urol Nephrol       Date:  2021-05-24       Impact factor: 2.370

3.  Dialyzer Reuse and Outcomes of High Flux Dialysis.

Authors:  Christos Argyropoulos; Maria-Eleni Roumelioti; Abdus Sattar; John A Kellum; Lisa Weissfeld; Mark L Unruh
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

4.  Application of Parametric Models to a Survival Analysis of Hemodialysis Patients.

Authors:  Maryam Montaseri; Jamshid Yazdani Charati; Fateme Espahbodi
Journal:  Nephrourol Mon       Date:  2016-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.